OGI
Price
$0.85Alerts
Change
-$0.00 (-0.00%)
Updated
Nov 11 closing price
Capitalization
126.36M
34 days until earnings call
Intraday BUY SELL Signals
SBFM
Price
$2.75Alerts
Change
-$0.10 (-3.51%)
Updated
Nov 11 closing price
Capitalization
10.51M
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

OGI vs SBFM

OGI vs SBFM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
OGI vs. SBFM commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGI is a StrongBuy and SBFM is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for OGI with price predictions
Nov 10, 2026

OGI's RSI Indicator recovers from oversold territory

The RSI Indicator for OGI moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In 30 of the 36 cases the stock moved higher. This puts the odds of a move higher at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where OGI advanced for three days, in 169 of 214 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

OGI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OGI as a result. In 77 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

The Moving Average Convergence Divergence Histogram (MACD) for OGI turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 37 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OGI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for OGI entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.260) is normal, around the industry mean (6.379). P/E Ratio (1.435) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (0.650) is also within normal values, averaging (183.387).

The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. OGI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OGI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for SBFM with price predictions
Nov 10, 2026

SBFM's RSI Indicator ascending out of oversold territory

The RSI Indicator for SBFM moved out of oversold territory on November 10, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 52 similar instances when the indicator left oversold territory. In 40 of the 52 cases the stock moved higher. This puts the odds of a move higher at 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SBFM just turned positive on October 23, 2026. Looking at past instances where SBFM's MACD turned positive, the stock continued to rise in 33 of 43 cases over the following month. The odds of a continued upward trend are 77%.

Following a +5.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where SBFM advanced for three days, in 117 of 166 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SBFM as a result. In 82 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SBFM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for SBFM entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.382) is normal, around the industry mean (6.379). P/E Ratio (-0.296) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (0.070) is also within normal values, averaging (183.387).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. SBFM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SBFM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
OGI vs SBFM: Fundamental Ratings
OGI
SBFM
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4696
PRICE GROWTH RATING
1..100
7698
P/E GROWTH RATING
1..100
9798
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBFM's Valuation (29) in the null industry is in the same range as OGI (37). This means that SBFM’s stock grew similarly to OGI’s over the last 12 months.

SBFM's Profit vs Risk Rating (100) in the null industry is in the same range as OGI (100). This means that SBFM’s stock grew similarly to OGI’s over the last 12 months.

OGI's SMR Rating (46) in the null industry is somewhat better than the same rating for SBFM (96). This means that OGI’s stock grew somewhat faster than SBFM’s over the last 12 months.

OGI's Price Growth Rating (76) in the null industry is in the same range as SBFM (98). This means that OGI’s stock grew similarly to SBFM’s over the last 12 months.

OGI's P/E Growth Rating (97) in the null industry is in the same range as SBFM (98). This means that OGI’s stock grew similarly to SBFM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OGISBFM
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
79%
Bullish Trend 2 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (OGI: $0.85 vs. SBFM: $2.85)
Brand notoriety: OGI and SBFM are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: OGI: 78% vs. SBFM: 6%
Market capitalization -- OGI: $126.36M vs. SBFM: $10.51M
OGI [@Pharmaceuticals: Generic] is valued at $126.36M. SBFM’s [@Pharmaceuticals: Generic] market capitalization is $10.51M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGI’s FA Score shows that 0 FA rating(s) are green while SBFM’s FA Score has 1 green FA rating(s).

  • OGI’s FA Score: 0 green, 5 red.
  • SBFM’s FA Score: 1 green, 4 red.
According to our system of comparison, OGI is a better buy in the long-term than SBFM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGI’s TA Score shows that 4 TA indicator(s) are bullish while SBFM’s TA Score has 3 bullish TA indicator(s).

  • OGI’s TA Score: 4 bullish, 4 bearish.
  • SBFM’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both OGI and SBFM are a good buy in the short-term.

Price Growth

OGI (@Pharmaceuticals: Generic) experienced а -6.92% price change this week, while SBFM (@Pharmaceuticals: Generic) price change was +4.01% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.20%. For the same industry, the average monthly price growth was -6.54%, and the average quarterly price growth was +10.31%.

Reported Earning Dates

OGI is expected to report earnings on Dec 15, 2026.

SBFM is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.20% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
Interact to see
Advertisement

SBFM and

Correlation & Price change

A.I.dvisor tells us that SBFM and SXTC have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBFM and SXTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
+3.64%
SXTC - SBFM
31%
Poorly correlated
-7.10%
OGI - SBFM
28%
Poorly correlated
-2.69%
CGC - SBFM
24%
Poorly correlated
-4.88%
TLRY - SBFM
24%
Poorly correlated
-7.02%
ELAN - SBFM
23%
Poorly correlated
-0.30%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
YXI22.480.15
+0.66%
ProShares Short FTSE China 50 (YXI)
HELX42.19N/A
N/A
Franklin Genomic Advancements ETF (HELX)
BAPR54.56-0.02
-0.04%
Innovator U.S. Equity Buffer ETF - April (BAPR)
JPHY48.64-0.28
-0.58%
JPMorgan Active High Yield ETF (JPHY)
FTRI17.06-0.42
-2.40%
First Trust Indxx Global Natural Resources Income ETF (FTRI)